LEE TIEN-LI (Chief Executive Officer) purchased 0.5% of their position (7K shares) of AARDVARK THERAPEUTICS, INC. on the open market
Open‑market purchase worth $101.4K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/12/2025ACC: 0001193125-25-318069
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2026
+7K
Net shares
Net buyer
$101.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
7K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7K
Price / share
$14.48
Trade value
$101.39K
% of position
0.5%
12/11/2025
1.54M→1.55M
Total
Net shares
+7K
Net value
$101.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2025 | P · Purchase | +7K | $14.48 | $101.39K | 0.5% | 1.54M | 1.55M |
| Total | +7K | $101.39K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.47M
Total
1.47M indirect1.47M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.47M | Indirect |
| Total | 1.47M | 1.47M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported